Antiviral Drugs - Lebanon

Lebanon

The projected revenue for the Antiviral Drugs market in Lebanon is expected to reach US$10.63m in 2024.
It is anticipated that the revenue will demonstrate an annual growth rate (CAGR 2024-2029) of 0.50%, leading to a market volume of US$10.90m by 2029.
When compared globally, United States is expected to generate the highest revenue of US$30,640.00m in 2024.
Despite the challenging economic and political situation in Lebanon, there is a growing demand for antiviral drugs due to the country's high prevalence of infectious diseases.

Key regions: Brazil, India, Australia, United States, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for Antiviral Drugs has been on the rise in Lebanon in recent years due to various factors.

Customer preferences: Customers in Lebanon have shown a growing interest in Antiviral Drugs due to the increasing prevalence of viral infections. The COVID-19 pandemic has also contributed to the surge in demand for Antiviral Drugs as people are more conscious about their health and are taking preventive measures to protect themselves from the virus.

Trends in the market: The Antiviral Drugs market in Lebanon has been witnessing a shift from traditional drugs to more advanced and innovative drugs. The market is also witnessing the introduction of new drugs that are more effective and have fewer side effects. The demand for generic drugs has also been on the rise due to their affordability.

Local special circumstances: Lebanon has been facing economic and political instability in recent years, which has affected the healthcare sector. The shortage of foreign currency and the devaluation of the Lebanese pound have made it difficult for patients to afford expensive drugs. The COVID-19 pandemic has also put a strain on the healthcare system, leading to a shortage of medical supplies and equipment.

Underlying macroeconomic factors: The Antiviral Drugs market in Lebanon is influenced by various macroeconomic factors such as government policies, healthcare infrastructure, and the prevalence of viral infections. The government's policies on healthcare spending and drug pricing play a crucial role in shaping the market. The healthcare infrastructure in Lebanon needs improvement, which can lead to better access to healthcare services and drugs. The prevalence of viral infections is also a key factor that drives the demand for Antiviral Drugs.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.